Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 2 |
2011 | 1 |
2012 | 3 |
2013 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of latent tuberculosis infection in HIV: shorter or longer?
Curr HIV/AIDS Rep. 2012 Sep;9(3):259-66. doi: 10.1007/s11904-012-0120-1.
Curr HIV/AIDS Rep. 2012.
PMID: 22581360
Free PMC article.
Review.
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A.
Maruri F, et al.
J Antimicrob Chemother. 2012 Apr;67(4):819-31. doi: 10.1093/jac/dkr566. Epub 2012 Jan 25.
J Antimicrob Chemother. 2012.
PMID: 22279180
Free PMC article.
Review.
Item in Clipboard
Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.
Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, Smith T, Hooper N, Maruri F, Warkentin J, Mitchel E, Sterling TR.
Devasia RA, et al.
Am J Respir Crit Care Med. 2009 Aug 15;180(4):365-70. doi: 10.1164/rccm.200901-0146OC. Epub 2009 May 29.
Am J Respir Crit Care Med. 2009.
PMID: 19483111
Free PMC article.
Item in Clipboard
Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.
Devasia RA, Blackman A, May C, Eden S, Smith T, Hooper N, Maruri F, Stratton C, Shintani A, Sterling TR.
Devasia RA, et al.
J Antimicrob Chemother. 2009 Jun;63(6):1173-8. doi: 10.1093/jac/dkp096. Epub 2009 Mar 28.
J Antimicrob Chemother. 2009.
PMID: 19329799
Free PMC article.
Item in Clipboard
Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosis.
Pettit AC, Bethel J, Hirsch-Moverman Y, Colson PW, Sterling TR; Tuberculosis Epidemiologic Studies Consortium.
Pettit AC, et al.
J Infect. 2013 Nov;67(5):424-32. doi: 10.1016/j.jinf.2013.07.015. Epub 2013 Jul 8.
J Infect. 2013.
PMID: 23845828
Free PMC article.
Item in Clipboard
Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.
Cortes CP, Wehbe FH, McGowan CC, Shepherd BE, Duda SN, Jenkins CA, Gonzalez E, Carriquiry G, Schechter M, Padgett D, Cesar C, Madero JS, Pape JW, Masys DR, Sterling TR; Caribbean, Central American, South American Network for HIV Research of the International Epidemiologic Databases to Evaluate AIDS.
Cortes CP, et al.
PLoS One. 2013 Sep 16;8(9):e74057. doi: 10.1371/journal.pone.0074057. eCollection 2013.
PLoS One. 2013.
PMID: 24066096
Free PMC article.
Item in Clipboard
High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.
Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A, Alexander C, Kaiga A, Stratton CW, Warkentin J, Tang YW, Sterling TR.
Devasia R, et al.
J Clin Microbiol. 2012 Apr;50(4):1390-6. doi: 10.1128/JCM.05286-11. Epub 2011 Dec 21.
J Clin Microbiol. 2012.
PMID: 22189117
Free PMC article.
Item in Clipboard
Cite
Cite